Lung Treatments Slow Damage From Fatal Lung Disease in Studies. Drugs made by Intermune Inc. and Boehringer Ingelheim GmbH slowed progression of a lung disease with no cure that often kills people three to five years after diagnosis, according to findings reported by two studies. Bloomberg, 05/19/2014. (Also see Pulmonary Fibrosis Research)
Death Risk Down With Pneumonia Antibiotic. Use of antibiotic regimens that included azithromycin were associated with a clinical benefit in older male veterans hospitalized with pneumonia. Med Page Today, 06/06/2014.
A good night's sleep really DOES boost your brain: Getting shut eye helps builds nerve cells linked with learning. A new study has revealed that sleep after learning strengthens connections between brain cells and enhances memory and the finding adds to evidence that a lack of shut-eye causes rogue proteins to build up in the eye increasing the risk for Alzheimer's disease. Mail Online, 06/06/2014.
Inflammation may help explain depression, diabetes link. People with both depression and diabetes have higher markers of inflammation in their blood than those with diabetes alone, a new study suggests. Reuters Health, 06/06/2014. (Also see Diabetes and Depression)
Psoriasis linked to worse quality of life for family members, too. Both psoriasis patients and the people who live with them say psoriasis negatively impacts their quality of life, and both groups tend to report more depression and anxiety than people not affected by the condition. Reuters Health, 06/06/2014. (Also see Psoriasis and Depression)
How Low Should We Go? (When It Comes To Blood Pressure). A new study suggests getting blood pressure as low as possible may not be critical for people with hypertension. Time Healthland, 06/17/2014. (Also see Heart Involvement)
Sitting Can Increase Your Risk of Cancer By Up to 66%. For a change, the cancer-promoter isn't something you eat or breathe, but something you do every day. Time Healthland, 06/17/2014. (Also see Cancer)
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: